Virios Therapeutics, Inc.
VIRI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $8,485,408 | $6,400,415 | $4,563,379 |
| - Cash | $10,126,710 | $13,402,809 | $17,539,004 | $0 |
| + Debt | $120,212 | $186,990 | $191,244 | $0 |
| Enterprise Value | – | -$4,730,411 | -$10,947,345 | $4,563,379 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$15,743,989 | -$3,923,115 | -$4,429,926 | -$12,223,900 |
| % Margin | – | – | – | – |
| Net Income | -$15,744,616 | -$3,807,353 | -$12,181,614 | -$12,859,207 |
| % Margin | – | – | – | – |
| EPS Diluted | -8.2 | -1.99 | -8.45 | -12.35 |
| % Growth | -312.1% | 76.4% | 31.6% | – |
| Operating Cash Flow | -$3,272,792 | -$4,026,118 | -$4,682,554 | -$8,787,587 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,272,792 | -$4,026,118 | -$4,682,554 | -$8,787,587 |